Karyopharm Therapeutics
Grace Brown has extensive experience in the pharmaceutical and biotechnology industries, currently serving as Senior Director of National Corporate Accounts for GPOs and Physician Networks at Karyopharm Therapeutics Inc. since February 2020, after previously holding the position of Director in the same area. Prior to that, Grace served as Associate Director of GI Oncology Marketing at Exelixis and held multiple roles at Clovis Oncology, including Senior Field Marketing Manager and Territory Manager. Earlier career highlights include positions at NanoString Technologies as NE Region Business Manager-Oncology Diagnostics and at Novartis in various roles, including Senior Oncology Sales Specialist. Grace began the career at IQVIA as District Sales Manager and Pharmaceutical Sales Representative. Educational credentials include a degree from the University of Dayton.
This person is not in any teams
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).